Clinical Trials Browser

Phase 2 × ACT001 × 90 days × Clear all

NCT06838676 2026-02-20

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Phase 2 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma